Trinity Biotech plc (TRIB)
| Previous close | 1.2000 |
| Open | 1.2500 |
| Bid | 1.1600 x 1100 |
| Ask | 1.3100 x 2900 |
| Day's range | 1.1800 - 1.2600 |
| 52-week range | 0.8600 - 2.5000 |
| Volume | |
| Avg. volume | 40,698 |
| Market cap | 46.11M |
| Beta (5Y monthly) | 1.34 |
| PE ratio (TTM) | 30.25 |
| EPS (TTM) | 0.0400 |
| Earnings date | 30 June 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 05 June 2015 |
| 1y target est | N/A |
- GlobeNewswire
Trinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEO
DUBLIN, Ireland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the appointment of Mr. Aris Kekedjian as CEO with effect from October 3, 2022. He succeeds Mr. Ronan O’Caoimh, co-founder of Trinity Biotech, who will remain on the Trinity Biotech plc Board of Directors to advise the Company going forward. In addition, Mr. Kekedjian has also assum
- GlobeNewswire
Trinity Biotech Announces Results of AGM
DUBLIN, Ireland, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the results of an Annual General Meeting (AGM). AGM Results On September 30, 2022 Trinity Biotech plc held an AGM of Shareholders at the Company’s headquarters at IDA Business Park, Bray, Co. Wicklow, Ireland. At the AGM, the Company’s shareholders approved the following resolutio
- Simply Wall St.
Is There Now An Opportunity In Trinity Biotech plc (NASDAQ:TRIB)?
Trinity Biotech plc ( NASDAQ:TRIB ), might not be a large cap stock, but it received a lot of attention from a...
